BD Revenues Up 3 Percent in Q1; Lowers Revenue Guidance for 2012 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson today said that its fiscal first-quarter revenues rose 3 percent year over year and slightly beat analyst estimates.

For the quarter ended Dec. 31, 2011, BD posted $1.89 billion in revenues, up from $1.84 billion during the first quarter of 2011, and surpassing analyst estimates of $1.88 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.